Linked Life Data

7859616

Source:http://linkedlifedata.com/resource/pubmed/id/7859616

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1995-3-17
pubmed:abstractText
We review the use of 1,5-anhydroglucitol (1,5 AG) in diagnosing and monitoring patients with diabetes. This six-carbon chain monosaccharide is one of the major polyols present in humans. Its concentration in serum is normally about 12 to 40 micrograms/ml. This substance is derived mainly from food, is well absorbed in the intestine, and is distributed to all organs and tissues. It is metabolically stable, being excreted in the urine when its level exceeds the renal threshold. It is reabsorbed in the renal tubules, and is competitively inhibited by glucosuria, which leads to a reduction in its level in serum. The correlation between this reduction and the amount of glucose present in urine is so close that 1,5 AG can be used as a sensitive, day-to-day, real-time marker of glycemic control. It provides useful information on current glycemic control and is superior to both HbA1c and fructosamine in detecting near-normoglycemia.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0168-8227
pubmed:author
pubmed:issnType
Print
pubmed:volume
24 Suppl
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S261-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control.
pubmed:affiliation
Second Department of Internal Medicine, University of Teikyo, Tokyo, Japan.
pubmed:publicationType
Journal Article, Review